Activist fans, another lite day. Activist news and stories below. Send tips to @activiststocks, sign up for our daily newsletter, and ICYMI the latest newsletter, it’s here.
News:
- Trian Fund and Nelson Peltz has dumped some of its Legg Mason shares. It lowered its stake by 5% and still owns 10.88% of the company.
- Kyle Bass is still at it with pharma patent challenges. Today, it’s Jazz Pharmaceuticals and its narcolepsy drug Xyrem. Recall Bass also announced challenges against Shire this week.
- Elliott Management finally books a win, getting Informatica sold. it’s going private for $48.75 a share. Note that Elliott went active with an 8% stake back in Jan.
Stories:
- @activistinvestr puts together a piece on the PwC report about activist...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full ArticleAlready a member? Log in here
